Movagharnejad K, Sharbatdaran M, Shefaee S, Kashifard M, Sedaghat S. HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma. Int J Mol Cell Med 2013; 2 (4) :199-203
URL:
http://ijmcmed.org/article-1-94-fa.html
HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma. مجله بین المللی سلولی و مولکولی. 1392; 2 (4) :199-203
URL: http://ijmcmed.org/article-1-94-fa.html
: (15211 مشاهده)
Gastric adenocarcinoma is the second leading cause of death due to cancer in the world and in advanced stages the prognosis is poor with current therapies. Over-expression of HER-2/neu has been seen in several cancers such as gastric cancer and its expression is associated with poor prognosis. The aim of this study is to evaluate the over-expression of HER-2/neu in gastric biopsy samples of patients with gastric carcinoma diagnosis and to evaluate its probable relationship with clinical and pathological findings. The over-expression of HER-2/neu was examined retrospectively by immunohistochemistry method in 60 paraffin embedded samples collected in Babol, Iran, between 2010 and 2011. The over-expression of HER-2/neu has been observed in 6 patients (10%) and this over-expression was greater in the intestinal type of gastric adenocarcinoma than the diffuse type (12% vs. 6%) however, no statistically significant correlation between HER-2/neu expression and subtype, degree of differentiation, tumor type and age was observed. This over-expression was greater in differentiated types than undifferentiated types (18% vs. 5%).
نوع مطالعه:
Original Article |
موضوع مقاله:
Histopathology دریافت: 1392/4/19 | پذیرش: 1392/9/3 | انتشار: 1392/9/3